Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × Esophagectomy × CNS × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 40 Other 1 CNS 1

Conditions

Esophageal Neoplasms 1 Brain Neoplasms 1

Interventions

Docetaxel 5 pembrolizumab 4 Radiotherapy 3 Paclitaxel 2 Erlotinib Hydrochloride 2 Carboplatin 2 Capecitabine 2 ulixertinib 1 tipifarnib 1 sacituzumab govitecan 1 regorafenib 1 oncogene protein E7, Human papillomavirus type 16 1 oblimersen 1 motexafin gadolinium 1 fludarabine 1 entinostat 1 brodalumab 1 aflibercept 1 Uncertainty 1 Trastuzumab 1 Thalidomide 1 Taxes 1 Ritonavir 1 Psychosocial Intervention 1 Pemetrexed 1 Observation 1 Nivolumab 1 NEO212 1 Magnetic Resonance Spectroscopy 1 Lapatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04654975 2024-07-03

METABREC

Universitaire Ziekenhuizen KU Leuven

10,000 enrolled

CNSGastrointestinal

Brain Neoplasms, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡